MPLA (Monophosphoryl Lipid A)

MPLA (Monophosphoryl Lipid A) refers to monophosphoryl lipid A, an effective, safe and non-toxic vaccine adjuvant. It is a highly specific TLR4 agonist that can activate the natural immune response, induce the production of cytokines, and increase the antigen uptake, antigen presentation and activation of specific T cells by antigen-presenting cells such as dendritic cells and monocytes. However, as a bacterial derivative, natural MPLA has many risks such as microbial contamination, unstable quality and sustainable supply. Therefore, our company has developed a fully synthetic monophosphoryl lipid A with a clear product structure and controllable quality, which can ensure the safety and effectiveness of vaccines